A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia von Noroozian, Maryam, Ghasemi, Sina, Hosseini, Seyed-Mohammad-Reza, Modabbernia, Amirhossein, Khodaie-Ardakani, Mohammad-Reza, Mirshafiee, Omid, Farokhnia, Mehdi, Tajdini, Masih, Rezaei, Farzin, Salehi, Bahman, Ashrafi, Mandana, Yekehtaz, Habibeh, Tabrizi, Mina, Akhondzadeh, Shahin

Volltext

Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study von Khodaie-Ardakani, Mohammad-Reza, Mirshafiee, Omid, Farokhnia, Mehdi, Tajdini, Masih, Hosseini, Seyed-Mohammad-Reza, Modabbernia, Amirhossein, Rezaei, Farzin, Salehi, Bahman, Yekehtaz, Habibeh, Ashrafi, Mandana, Tabrizi, Mina, Akhondzadeh, Shahin

Volltext

N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study von FAROKHNIA, Mehdi, AZARKOLAH, Anita, MOGHADAM, Marzieh, GHARIBI, Fardin, MIRSHAFIEE, Omid, AKHONDZADEH, Shahin, ADINEHFAR, Forod, KHODAIE-ARDAKANI, Mohammad-Reza, HOSSEINI, Seyed-Mohammad-Reza, YEKEHTAZ, Habibeh, TABRIZI, Mina, REZAEI, Farzin, SALEHI, Bahman, SADEGHI, Seyed-Mohammad-Hossein

Volltext

Double-Blind, Placebo-Controlled Trial of Risperidone Plus Amantadine in Children With Autism: A 10-Week Randomized Study von MOHAMMADI, Mohammad-Reza, YADEGARI, Nourrollah, HASSANZADEH, Elmira, FAROKHNIA, Mehdi, YEKEHTAZ, Habibeh, MIRSHAFIEE, Omid, AKHONDZADEH, Shahin

Volltext